J0582 Bivalirudin (endo) 1 milligrams
Also known as: bivalirudin, Angiomax, direct thrombin inhibitor
Bivalirudin injection (Angiomax/endoluminal use), 1 milligram, a direct thrombin inhibitor anticoagulant for percutaneous coronary intervention.
In Plain Language
blood thinner for stent procedures; anticoagulant injection
Clinical Context
Used during percutaneous coronary interventions (PCI/angioplasty) to prevent thrombotic complications. Preferred alternative to heparin in patients with heparin-induced thrombocytopenia (HIT) due to direct thrombin inhibition mechanism.
RVU Information
CPT J0582 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0582?
CPT J0582 (Bivalirudin (endo) 1 milligrams) is a J Codes (Drugs) code. Bivalirudin injection (Angiomax/endoluminal use), 1 milligram, a direct thrombin inhibitor anticoagulant for percutaneous coronary intervention.
How is J0582 administered?
CPT J0582 is administered by a healthcare provider, typically via injection or infusion. Used during percutaneous coronary interventions (PCI/angioplasty) to prevent thrombotic complications. Preferred alternative to heparin in patients with heparin-induced thrombocytopenia (HIT) due to direct thrombin inhibition mechanism. It is used by cardiology, interventional cardiology, hospital medicine.
When is CPT J0582 used?
Used during percutaneous coronary interventions (PCI/angioplasty) to prevent thrombotic complications. Preferred alternative to heparin in patients with heparin-induced thrombocytopenia (HIT) due to direct thrombin inhibition mechanism.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.